Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 78 results

Search by release date:: Jan, 2012 ～ Dec, 2012

December 25, 2012
Otsuka Pharmaceutical

L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms approved for Carnitine Deficiency
December 25, 2012
Otsuka Pharmaceutical

The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome
December 25, 2012
Otsuka Pharmaceutical

Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
December 25, 2012
Otsuka Holdings

Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
December 7, 2012
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory and Mitsui enter into IV solutions business in India
December 7, 2012
Otsuka Holdings

Establishment of Joint Venture Company (Subsidiary) in India
November 30, 2012
Taiho Pharmaceutical

Announcement; Launch of 5-HT3 Receptor Antagonist Aloxi® I.V. infusion bag 0.75mg
November 20, 2012
Otsuka Pharmaceutical

Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
November 6, 2012
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Abdi İbrahim Established a Joint Venture Company for Pharmaceutical Sales in Turkey
November 5, 2012
Otsuka Pharmaceutical

Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
November 5, 2012
Otsuka Pharmaceutical

Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
October 29, 2012
Otsuka Pharmaceutical

Kenja no Shokutaku Double Support Food for Specified Health Use with Dual Function Suppressing the Absorption of Both Sugars and Lipids, to Launch in Japan for the First Time
October 29, 2012
Otsuka Holdings

Otsuka Medical Devices and Pioneer Form an Alliance in the Medical Endoscope Business
October 25, 2012
Otsuka Holdings

Otsuka announces 2012 third quarter U.S. net sales figures of ABILIFY®
October 1, 2012
Otsuka Pharmaceutical

Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - America's Number One Dietary Supplement Brand
September 28, 2012
Taiho Pharmaceutical

ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis, Intra-abdominal Abscess, Cholecystitis, and Cholangitis
September 24, 2012
Otsuka Pharmaceutical

New "Poppy Seed & Lemon" from Gerblé to launch on October 15 The No.1 French Health Food Brand now in 3,000 stores nationwide
September 18, 2012
Taiho Pharmaceutical

Clinical Trial (JASPAC 01) of TS-1 for Resected Pancreatic Cancer
September 14, 2012
Otsuka Pharmaceutical

Kyowa Hakko Kirin Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to Hematopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries & Regions
September 12, 2012
Otsuka Holdings

Otsuka and Lundbeck Announce U.S. Food and Drug Administration Acknowledges Receipt of Resubmission of New Drug Application for Aripiprazole Depot Formulation
September 3, 2012
Otsuka Pharmaceutical

ABILIFY® ,The First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
September 3, 2012
Otsuka Holdings

ABILIFY® ,The First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
August 29, 2012
Otsuka Pharmaceutical

Otsuka, the First Pharmaceutical Company in Japan to Have Been Certified for "ISO22301", the International Standard for Business Continuity Management
August 28, 2012
Taiho Pharmaceutical

Results of a Phase II Clinical Trial for the Novel Antitumor Agent TAS-102 Posted on the Electronic Edition of The Lancet Oncology
August 1, 2012
Otsuka Pharmaceutical

Vasopressin V2-Receptor Antagonist, Samsca® Tablets Were Filed Additional Indication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
August 1, 2012
Otsuka Pharmaceutical

Pocari Sweat Launches in Vietnam through New Joint Venture Company. Vietnam Launch is the17th Market in the World Where the Pocari Sweat is Sold
July 30, 2012
Otsuka Pharmaceutical

Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
July 30, 2012
Otsuka Holdings

Otsuka Holdings Announces Completion of Share Repurchase
July 27, 2012
Otsuka Holdings

OTSUKA RECEIVES COMPLETE RESPONSE LETTER FOR EXTENDED-RELEASE INJECTABLE SUSPENSION OF ARIPIPRAZOLE
July 26, 2012
Otsuka Holdings

Otsuka announces 2012 second quarter U.S. net sales figures of ABILIFY®